Evaluation of response to stereotactic radiosurgery in patients with radioresistant brain metastases


Sayan M., Zoto M., Sahin B., Kefelioglu E., Wang S., Kurup V., ...More

RADIATION ONCOLOGY JOURNAL, vol.37, no.4, pp.265-270, 2019 (Journal Indexed in ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 37 Issue: 4
  • Publication Date: 2019
  • Doi Number: 10.3857/roj.2019.00409
  • Title of Journal : RADIATION ONCOLOGY JOURNAL
  • Page Numbers: pp.265-270

Abstract

Purpose: Renal cell carcinoma (RCC) and melanoma have been considered 'radioresistant' due to the fact that they do not respond to conventionally fractionated radiation therapy. Stereotactic radiosurgery (SRS) provides high-dose radiation to a defined target volume and a limited number of studies have suggested the potential effectiveness of SRS in radioresistant histologies. We sought to determine the effectiveness of SRS for the treatment of patients with radioresistant brain metastases.